Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anesthesiologist- versus surgeon-performed liposomal bupivacaine intercostal nerve block after VATS
ChiCTR2500101867Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2025
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Total opioid consumption within 48 hours after surgery. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500101867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101867.